GATC Health Corp
- Biotech or pharma, therapeutic R&D
GATC Health's predictive AI, Multiomics Advanced Technology (MAT), simulates human systems biology to predict safety, efficacy, and off-target effects for virtually any disease. An independent third-party study confirmed MAT's capabilities--concluding 91% accuracy in predicting a molecule's negative activation on biological targets and 86% accuracy in predicting positive activation on biological targets. GATC is using its platform to discover novel therapeutics and expedite validation of other researchers' investigative compounds. Biopharmaceutical companies are using GATC's AI analyses to conserve capital and to efficiently validate their pipelines.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}